Experiences and opinions of multi-professional non-medical oncology prescribers on post-qualification training: a qualitative study.

Drug prescriptions Education Medical oncology Nurses Pharmacists Radiology

Journal

International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 08 12 2021
accepted: 04 03 2022
pubmed: 6 4 2022
medline: 18 6 2022
entrez: 5 4 2022
Statut: ppublish

Résumé

Within the UK, a non-medical prescriber is a non-medical healthcare professional who has undertaken post-registration training to gain prescribing rights. Lack of post-qualification NMP training has previously been identified as a barrier to the development of oncology non-medical prescribing practice. To explore the experiences and opinions of multi-professional non-medical oncology prescribers on post-qualification training. Nine out of 30 oncology non-medical prescribers (three nurses, three pharmacists and three radiographers) from a single cancer centre in Wales, were selected from a study site NMP database using randomisation sampling within Microsoft® Excel. Participants were interviewed using a validated and piloted semi-structured interview design on the topic of post-qualification training for non-medical prescribers. Participants were invited via organisational email. Interviews were audio-recorded and transcribed verbatim. Anonymised data were thematically analysed aided by NVivo® software. Main themes identified: experience related to training, competency, support and training methods. Competency assessment methods discussed were the annual non-medical prescriber appraisal, peer review and a line manager's overarching appraisal. Support requirements identified included greater consultant input to help non-medical prescribers identify training and peer support opportunities. Organisational support was requested regarding regular study leave and governance around clinical judgement and errors. The need for regular structured in-house training related to non-medical prescriber's level of experience was identified. Development of organisation-led governance strategies and in-house training programmes will support training equity for all non-medical prescribers within the organisation.

Sections du résumé

BACKGROUND BACKGROUND
Within the UK, a non-medical prescriber is a non-medical healthcare professional who has undertaken post-registration training to gain prescribing rights. Lack of post-qualification NMP training has previously been identified as a barrier to the development of oncology non-medical prescribing practice.
AIM OBJECTIVE
To explore the experiences and opinions of multi-professional non-medical oncology prescribers on post-qualification training.
METHOD METHODS
Nine out of 30 oncology non-medical prescribers (three nurses, three pharmacists and three radiographers) from a single cancer centre in Wales, were selected from a study site NMP database using randomisation sampling within Microsoft® Excel. Participants were interviewed using a validated and piloted semi-structured interview design on the topic of post-qualification training for non-medical prescribers. Participants were invited via organisational email. Interviews were audio-recorded and transcribed verbatim. Anonymised data were thematically analysed aided by NVivo® software.
RESULTS RESULTS
Main themes identified: experience related to training, competency, support and training methods. Competency assessment methods discussed were the annual non-medical prescriber appraisal, peer review and a line manager's overarching appraisal. Support requirements identified included greater consultant input to help non-medical prescribers identify training and peer support opportunities. Organisational support was requested regarding regular study leave and governance around clinical judgement and errors. The need for regular structured in-house training related to non-medical prescriber's level of experience was identified.
CONCLUSION CONCLUSIONS
Development of organisation-led governance strategies and in-house training programmes will support training equity for all non-medical prescribers within the organisation.

Identifiants

pubmed: 35378673
doi: 10.1007/s11096-022-01396-6
pii: 10.1007/s11096-022-01396-6
pmc: PMC9200693
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

698-708

Informations de copyright

© 2022. The Author(s).

Références

Br J Clin Pharmacol. 2012 Apr;73(4):656-60
pubmed: 22035442
J Health Serv Res Policy. 2008 Oct;13(4):215-21
pubmed: 18806179
Res Social Adm Pharm. 2021 Mar;17(3):632-637
pubmed: 32461165
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Clin Nurs. 2012 Jul;21(13-14):2044-53
pubmed: 22672462
Res Social Adm Pharm. 2016 Jan-Feb;12(1):41-55
pubmed: 26048711
Palliat Med. 2007 Jun;21(4):273-7
pubmed: 17656402
Br J Nurs. 2019 Jun 13;28(11):715-720
pubmed: 31188669
Oman Med J. 2011 Jul;26(4):219-22
pubmed: 22043423
Nurse Educ Today. 2007 Oct;27(7):685-96
pubmed: 17123668
Int J Pharm Pract. 2019 Dec;27(6):479-489
pubmed: 31287208
J Adv Nurs. 2018 Jan;74(1):65-74
pubmed: 28677174
J Oncol Pharm Pract. 2019 Oct;25(7):1558-1563
pubmed: 30180775
BMC Med Educ. 2014 Aug 25;14:177
pubmed: 25152074
BMJ Open. 2018 Sep 19;8(9):e024161
pubmed: 30232116
Clin Med (Lond). 2016 Oct;16(5):470-474
pubmed: 27697813
Nurse Educ Today. 2015 Jan;35(1):227-31
pubmed: 25240679
J Adv Nurs. 2014 Nov;70(11):2506-17
pubmed: 24698501
Int J Pharm Pract. 2013 Apr;21(2):82-91
pubmed: 23419239

Auteurs

Sophie E Harding (SE)

Velindre Cancer Centre, Cardiff, UK. hardinse@aston.ac.uk.
Aston Pharmacy School, Aston University, Birmingham, UK. hardinse@aston.ac.uk.

Christopher A Langley (CA)

Aston Pharmacy School, Aston University, Birmingham, UK.

Annabel Borley (A)

Velindre Cancer Centre, Cardiff, UK.

Bethan Tranter (B)

Velindre Cancer Centre, Cardiff, UK.

David R P Terry (DRP)

Aston Pharmacy School, Aston University, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH